37699-43-7Relevant articles and documents
INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
-
Page/Page column 122, (2018/04/20)
The present disclosure provides compounds useful as inhibitors of SARM1 NADase activity, compositions thereof, and methods of using the same. The present disclosure provides compounds useful for treating a neurodegenerative or neurological disease or disorder, compositions thereof, and methods of using the same.
A 2, 3 - dimethyl -4 - nitro pyridine - N - oxide synthesis method
-
Paragraph 0013; 0018-0027, (2017/04/29)
The invention discloses a synthesis method of 2,3-dimethyl-4-nitropyridine-N-oxide and belongs to the field of chemical industry. The synthesis method comprises the following steps: mixing 2,3-dimethylpyridine-N-oxide with thickened sulfuric acid to form a mixed solution, and dropwise adding the sulfuric acid solution of potassium nitrate to the mixed solution under the condition that the temperature ranges from -10 DEG C to 20 DEG C; after finishing the dropwise addition, reacting under the condition that the temperature ranges from 80 DEG C to 120 DEG C. According to the synthesis method, as potassium nitrate is taken as a nitration reagent to take the place of thickened nitric acid or fuming nitric acid, the reaction time is greatly shortened, no brown yellow smoke is generated in the reaction and after-treatment processes, the operating environment is friendly, the environmental pollution problem caused by the use of a large quantity of nitric acid is reduced, and meanwhile, the reaction yield is also increased to a certain extent; in today when the environmental problem is increasingly emphasized, potassium nitrate can be applied to complete the nitration reaction well instead of nitric acid.
Design and synthesis of N-Aryl isothioureas as a novel class of gastric H+/K+-ATPase inhibitors
Ma, Chao,Wu, Anhui,Wu, Yongqi,Ren, Xuhong,Cheng, Maosheng
, p. 891 - 900 (2014/01/06)
To find new H+/K+-ATPase inhibitors for the treatment of peptic ulcer disease, a series of novel N-aryl isothiourea derivatives were synthesized and their structures were identified by 1H NMR and GC-MS. The effects of these compounds on inhibiting gastric acid secretion were evaluated by the guinea pig stomach mucous membrane study with pantoprazole magnesium as a positive control. The results showed that, of the 37 N-aryl isothiourea compounds synthesized, 20 compounds have comparable or stronger gastric acid inhibitory activities than that of pantoprazole magnesium. The quantitative structure-activity relationships (QSARs) of the N-aryl isothiourea compounds were also studied by comparative molecular field analysis (CoMFA) computation, and the model structure that was supposed to give more powerful bioactivities was finally predicted. A series of novel N-aryl isothiourea derivatives were synthesized and evaluated for their effects of inhibiting gastric acid secretion using the guinea pig stomach mucous membrane study with pantoprazole magnesium as a positive control. Compounds 2c, 2e, and 2k have higher bioactivity. The quantitative structure-activity relationships also defined these structural requirements.